Effect of dietary n-3 and n-6 oils with and without food restriction on activity of antioxidant enzymes and lipid peroxidation in livers of cyclophosphamide treated autoimmune-prone nzb/w female mice

Journal of the American College of Nutrition

Volumn 22, Issue 5, 2003, Pages 388-399

  Bhattacharya, Arunabh ^a   Lawrence, Richard A ^a   Krishnan, Aparna ^a   Zaman, Khaliquz ^a   Sun, Dongxu ^a   Fernandes, Gabriel ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Anti DNA antibodies; Antioxidant enzymes; Cyclophosphamide; Fatty acid composition; Fish oil; Lipid peroxidation; Liver; NZB W mice

Indexed keywords

ANTIOXIDANT; CYCLOPHOSPHAMIDE; DNA ANTIBODY; FISH OIL; FREE RADICAL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; BODY WEIGHT; CONTROLLED STUDY; DIET RESTRICTION; DIETARY INTAKE; DRUG EFFECT; DRUG METABOLISM; ENZYME ACTIVITY; KIDNEY FUNCTION; LIPID COMPOSITION; LIPID PEROXIDATION; LIVER HOMOGENATE; LIVER METABOLISM; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEINURIA; RISK BENEFIT ANALYSIS;

ANIMALS; AUTOIMMUNE DISEASES; CATALASE; CORN OIL; CYCLOPHOSPHAMIDE; DIET, REDUCING; DISEASE SUSCEPTIBILITY; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; FISH OILS; GLUTATHIONE PEROXIDASE; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; LIPID PEROXIDATION; LIVER; MICE; MICE, INBRED NZB; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

ANIMALIA; FELIS CATUS; ZEA MAYS;

EID: 0141919752     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2003.10719322     Document Type: Article

References (74)

1. Theofilopoulos AN, Kofler R, Singer PA, Dixon FJ: Molecular genetics of murine lupus models. Adv Immunol 46:61-109, 1989.
2. Foster MH: Relevance of systemic lupus erythematosus nephritis animal models to human disease. Semin Nephrol 19:12-24, 1999.
3. Fernandes G, Troyer DA, Jolly CA: The effects of dietary lipids on gene expression and apoptosis. Proc Nutr Soc 57:543-550, 1998.
4. Daikh DI, Wofsy D: Cutting edge: reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide. J Immunol 166: 2913-2916, 2001.
5. Zincke H, Woods JE: Donor pretreatment in cadaver renal transplantation. Surg Gynecol Obstet 145:183-188, 1977.
6. Livingston R, Carter S: “Single Agents in Cancer Chemotherapy.” New York: Plenum, 1970.
7. Russell PJ, Hicks JD, Burnet FM: Cyclophosphamide treatment of kidney disease in (NZB _ NZW) F1 mice. Lancet 1:1280-1284, 1966.
8. Russell PJ, Hicks JD: Cyclophosphamide treatment of renal disease in (NZB _ NZW) F1 hybrid mice. Lancet 1:440-441, 1968.
9. Casey TP: Immunosuppression by cyclophosphamide in NZB X NZW mice with lupus nephritis. Blood 32:436-444, 1968.
10. Hurd ER: Effect of cyclophosphamide on interstitial nephritis and tubule cell proliferation in NZB/NZE mice. J Immunol 119:1552-1555, 1977.
11. Boumpas DT, Austin 3rd HA, Vaughn EM, Klippel JH, Steinberg AD, Yarboro CH, Balow JE: Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 340:741-745, 1992.
12. Cameron JS: Lupus nephritis. J Am Soc Nephrol 10:413-424, 1999.
13. Gelfand MC, Steinberg AD: Therapeutic studies in NZB-W mice. II. Relative efficacy of azathioprine, cyclophosphamide and methylprednisolone. Arthritis Rheum 15:247-252, 1972.
14. Steinberg AD, Steinberg SC: Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only. Arthritis Rheum 34:945-950, 1991.
15. Austin 3rd HA, Klippel JH, Balow JE, le Riche NG, Steinberg AD, Plotz PH, Decker JL: Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314:614-619, 1986.
16. Glisic B, Popovic M, Popovic R, Mitrovic D, Stefanovic D, Dimitrijevic M: High doses of cyclophosphamide in the treatment of severe systemic lupus erythematosus. Transplant Proc 33:2300-2301, 2001.
17. Patel JM, Block ER, Hood CI: Biochemical indices of cyclophosphamide- induced lung toxicity. Toxicol Appl Pharmacol 76:128-138, 1984.
18. Patel JM, Block ER: Cyclophosphamide-induced depression of the antioxidant defense mechanisms of the lung. Exp Lung Res 8:153-165, 1985.
19. Venkatesan N, Chandrakasan G: Modulation of cyclophosphamide- induced early lung injury by curcumin, an anti-inflammatory antioxidant. Mol Cell Biochem 142:79-87, 1995.
20. Kaya H, Oral B, Ozguner F, Tahan V, Babar Y, Delibas N: The effect of melatonin application on lipid peroxidation during cyclophosphamide therapy in female rats. Zentralbl Gynakol 121:499-502, 1999.
21. Lear L, Nation RL, Stupans I: Effects of cyclophosphamide and adriamycin on rat hepatic microsomal glucuronidation and lipid peroxidation. Biochem Pharmacol 44:747-753, 1992.
22. Mathew S, Kuttan G: Antioxidant activity of Tinospora cordifolia and its usefulness in the amelioration of cyclophosphamide induced toxicity. J Exp Clin Cancer Res 16:407-411, 1997.
23. Premkumar K, Pachiappan A, Abraham SK, Santhiya ST, Gopinath PM, Ramesh A: Effect of Spirulina fusiformis on cyclophosphamide and mitomycin-C induced genotoxicity and oxidative stress in mice. Fitoterapia 72:906-911, 2001.
24. Khan S, Ramwani JJ, O’Brien PJ: Hepatocyte toxicity of mechlorethamine and other alkylating anticancer drugs. Role of lipid peroxidation. Biochem Pharmacol 43:1963-1967, 1992.
25. Rekha PS, Kuttan G, Kuttan R: Effect of Brahma Rasayana on antioxidant systems and cytokine levels in mice during cyclophosphamide administration. J Exp Clin Cancer Res 20:219-223, 2001.
26. Look MP, Musch E: Lipid peroxides in the polychemotherapy of cancer patients. Chemotherapy 40:8-15, 1994.
27. Unnikrishnan MC, Soudamini KK, Kuttan R: Chemoprotection of garlic extract toward cyclophosphamide toxicity in mice. Nutr Cancer 13:201-207, 1990.
28. Capel ID, Leach D, Dorrell HM: Vitamin E retards the lipoperoxidation resulting from anticancer drug administration. Anticancer Res 3:59-62, 1983.
29. Simopoulos AP: Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 54:438-463, 1991.
30. Fernandes G, Venkatraman J: Role of w-3 fatty acids in health and disease. Nutrition Res 13:S19-S45, 1993.
31. Kehn P, Fernandes G: The importance of omega-3 fatty acids in the attenuation of immune-mediated diseases. J Clin Immunol 21:99-101, 2001.
32. Cave Jr WT: Dietary n-3 ω-3) polyunsaturated fats and breast cancer. Nutrition 12:S39-S42, 1996.
33. Rose DP, Connolly JM: Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther 83:217-244, 1999.
34. Prickett JD, Robinson DR, Steinberg AD: Dietary enrichment with the polyunsaturated fatty acid eicosapentaenoic acid prevents proteinuria and prolongs survival in NZB × NZWF1 mice. J Clin Invest 68:556-559, 1981.
35. Fernandes G, Bysani C, Venkatraman JT, Tomar V, Zhao W: Increased TGF-beta and decreased oncogene expression by omega- 3 fatty acids in the spleen delays onset of autoimmune disease in B/W mice. J Immunol 152:5979-5987, 1994.
36. Prickett JD, Robinson DR, Steinberg AD: Effects of dietary enrichment with eicosapentaenoic acid upon autoimmune nephritis in female NZB/NZW/F1 mice. Arth Rheum 26:133-139, 1983.
37. James MJ, Cleland LG: Dietary n-3 fatty acids and therapy for rheumatoid arthritis. Semin Arthritis Rheum 27:85-97, 1997.
38. Fernandes G, Jolly CA: Nutrition and autoimmune disease. Nutr Rev 56: S161-S169, 1998.
39. Donadio Jr JV, Bergstralh EJ, Offord KP, Spencer DC, Holley KE: A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group. N Engl J Med 331:1194-1199, 1994.
40. Chandrasekar B, McGuff HS, Aufdermorte TB, Troyer DA, Talal N, Fernandes G: Effects of calorie restriction on transforming growth factor beta 1 and proinflammatory cytokines in murine Sjogren’s syndrome. Clin Immunol Immunopathol 76:291-296, 1995.
41. Miller BC, Lau HW, Tyler NE, Cottam GL: Liver composition and lipid metabolism in NZB/W F1 female mice fed dehydroisoandrosterone. Biochim Biophys Acta 962:25-36, 1988.
42. Fernandes G: Nutritional factors: Modulating effects on immune function and aging. Pharmacol Revs 36:123S-129S, 1984.
43. Hart RW, Leakey JE, Chou M, Duffy PH, Allaben WT, Feuers RJ: Modulation of chemical toxicity by modification of caloric intake. Adv Exp Med Biol 322:73-81, 1992.
44. Jolly C, Muthukumar A, Reddy Avula C, Troyer D, Fernandes G: Life span is prolonged in food-restricted autoimmune-prone (NZB × NZW)F(1) mice fed a diet enriched with (n-3) fatty acids. J Nutr 131:2753-2760, 2001.
45. Chang SC, Chiang BL, Wu WM, Lin BF: Different dietary fats influence serum and tissue lipids and anti-cardiolipin antibody levels in autoimmune-prone NZB/W F1 mice. Br J Nutr 81:331-340, 1999.
46. Venkatraman JT, Chandrasekar B, Kim JD, Fernandes G: Effects of n-3 and n-6 fatty acids on the activities and expression of hepatic antioxidant enzymes in autoimmune-prone NZB _ NZW F1 mice. Lipids 29:561-568, 1994.
47. Venkatraman JT, Chandrasekar B, Kim JD, Fernandes G: Genotype effects on the antioxidant enzymes activity and mRNA expression in liver and kidney tissues of autoimmune-prone MRL/MpJ-lpr/lpr mice. Biochim Biophys Acta 1213:167-175, 1994.
48. Venkatraman JT, Poomchai Angkeow MS, Fernandes G: Effects of food restriction on antioxidant defense system in exercised rats. Nutrition Research. 18:283-298, 1998.
49. Xia E, Rao G, Van Remmen H, Heydari AR, Richardson A: Activities of antioxidant enzymes in various tissues of male Fischer 344 rats are altered by food restriction. J Nutr 125:195-201, 1995.
50. Ikeda I, Wakamatsu K, Inayoshi A, Imaizumi K, Sugano M, Yazawa K: alpha-Linolenic, eicosapentaenoic and docosahexaenoic acids affect lipid metabolism differently in rats. J Nutr 124: 1898-1906, 1994.
51. Avula CPR, Fernandes G: Modulation of Lipid Peroxidation and Antioxidant Enzymes in Murine Salivary Gland and Liver Tissue by Dietary Fatty Acid Ethyl Esters. Life Sciences 65:2373-2383, 1999.
52. Avula CP, Fernandes G: Modulation of antioxidant enzymes and apoptosis in mice by dietary lipids and treadmill exercise. J Clin Immunol 19:35-44, 1999.
53. Contreras G, Roth D, Pardo V, Striker LG, Schultz DR: Lupus nephritis: a clinical review for practicing nephrologists. Clin Nephrol 57:95-107, 2002.
54. Bligh JA, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-920, 1959.
55. Kates M: “Techniques of Lipidology: Isolation, Analysis and Identification of Lipids.” New York: Elsevier, 1986.
56. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358, 1979.
57. Johansson LH, Borg LA: A spectrophotometric method for determination of catalase activity in small tissue samples. Anal Biochem 174:331-336, 1988.
58. Flohe L, Otting F: Superoxide dismutase assays. Methods Enzymol 105:93-104, 1984.
59. Tappel AL: Glutathione peroxidase and hydroperoxides. Methods Enzymol 52:506-513, 1978.
60. Habig WH, Pabst MJ, Jakoby WB: Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130-7139, 1974.
61. Venkatraman JT, Chu WC: Effects of dietary omega-3 and omega- 6 lipids and vitamin E on serum cytokines, lipid mediators and anti-DNA antibodies in a mouse model for rheumatoid arthritis. J Am Coll Nutr 18:602-613, 1999.
62. Sies H: Oxidative stress: oxidants and antioxidants. Exp Physiol 82:291-295, 1997.
63. Jacob RA, Burri BJ: Oxidative damage and defense. Am J Clin Nutr 63:985S-990S, 1996.
64. Gutteridge JM, Halliwell B: The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 15: 129-135, 1990.
65. Richelle M, Turini ME, Guidoux R, Tavazzi I, Metairon S, Fay LB: Urinary isoprostane excretion is not confounded by the lipid content of the diet. FEBS Lett 459:259-262, 1999.
66. De la Fuente M, Victor VM: Anti-oxidants as modulators of immune function. Immunol Cell Biol 78:49-54, 2000.
67. Slater TF: Free-radical mechanisms in tissue injury. Biochem J 222:1-15, 1984.
68. Halliwell B, Gutteridge JM: “Free Radicals in Biology and Medicine,” 2nd ed. Oxford: Clarendon Press, 1989.
69. Dumontet C, Drai J, Thieblemont C, Hequet O, Espinouse D, Bouafia F, Salles G, Coiffier B: The superoxide dismutase content in erythrocytes predicts short-term toxicity of high-dose cyclophosphamide. Br J Haematol 112:405-409, 2001.
70. Venkatraman JT, Angkeow P, Satsangi N, Fernandes G: Effects of dietary n-6 and n-3 lipids on antioxidant defense system in livers of exercised rats. J Am Coll Nutr 17:586-594, 1998.
71. Kappus H, Sies H: Toxic drug effects associated with oxygen metabolism: redox cycling and lipid peroxidation. Experientia 37: 1233-1241, 1981.
72. Koizumi A, Weindruch R, Walford RL: Influences of dietary restriction and age on liver enzyme activities and lipid peroxidation in mice. J Nutr 117:361-367, 1987.
73. Alterman MA, Carvan MJ, Busbee DL: Ethoxyresorufin and pentoxyresorufin O-dealkylation by hepatic microsomes from female Fischer 344 rats: effects of age and diet. Mech Ageing Dev 77:1-11, 1994.
74. Demoz A, Willumsen N, Berge RK: Eicosapentaenoic acid at hypotriglyceridemic dose enhances the hepatic antioxidant defense in mice. Lipids 27:968-971, 1992.